Accessibility Help | Sitemap | Contact Us | Customer Support CALL 1-800-275-4524
United States Change Country
Careers | Investor Relations | News & Media | Events | KCI Recycling | About KCI
Home  |  Conditions  |  Products  |  Clinical Evidence  |  Education and Training  |  For Patients  |  Customer Support  |  Suppliers
You are here: Home > For Patients > Patient Stories > Oliver's Story

Oliver's Story

Learn about how ABThera™ Open Abdomen System helped one millworker continue his life.

Photo of Oliver, ABThera Patient

In January 2010, Oliver Glenn, a millworker in Port Huron, Michigan, was working at a construction site when he fell 35 feet and landed on a beam. He developed abdominal compartment syndrome. His surgeons applied KCI's ABThera™ Open Abdomen System and, to their surprise, Mr. Glenn was able to be closed up within 24 hours of being placed on the ABThera™ System. Mr. Glenn has expressed how grateful he is to KCI for creating the ABThera™ Open Abdomen System because without it, he believes he might not have seen his wife or kids again.



This video depicts one patient's results with the Abthera Open Abdomen System. Results and outcomes should not be interpreted as a guarantee or warranty of similar results. Individual results may vary depending on the patient's circumstances and condition.

NOTE: Specific indications, contraindications, warnings, precautions and safety information exist for KCI products and therapies. Please consult a physician and product instructions for use prior to application.

  • KCI Express
  • Share on
  • Share on Twitter
  • Visit our YouTube page

Important Message for Patients

Terms of Use | Privacy Notice | Safe Harbor Policy | Contact Us | News Feed

Copyright © 1998 - 2013 KCI Licensing, Inc. All Rights Reserved.    DSL# 09-03-193
The information included in this Web site has been prepared for and is intended for viewing exclusively within the United States of America. This Web site contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please consult individual country sites for approved uses and any applicable restrictions.